NexOptic Edges Closer to Commercialization

VANCOUVER, BC, Sept. 8, 2023 /PRNewswire/ – (“NexOptic“) (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1), a company developing cutting-edge AI and imaging technologies, announces that it is nearing the point of first revenue. NexOptic Technology Corp and Pristine Surgical LLC are in an exclusive SaaS model partnership whereby NexOptic’s artificial intelligence (AI) powered imaging technology is licensed for use into Pristine’s single-use endoscopic visualization platform called Summit™. Summit is a single-use surgical arthroscope designed to make more efficient, consistent, and safe endoscopy. NexOptic’s ALIIS™ provides an important AI image enhancement to optimize the surgeon’s 4K surgical view. Summit is delivered in single-use, sterile packaging, is simple to set up, improves predictability and workflow, and its transparent pricing model reduces costs for ambulatory surgery centers (ASCs). Summit also includes a proprietary cloud-based software – Pristine Connect™ – allowing for seamless video capture, automated inventory management, and a growing portfolio of value-added services. 

Read more at prnewswire.com

Related news for (NXOPF)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.